• 1
    Wood LJ, Inman MD, Watson RM, Foley R, Denburg JA, O’Byrne PM. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med 1998;157:99105.
  • 2
    Sehmi R, Howie K, Sutherland DR, Schragge W, O’Byrne PM, Denburg JA. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects. Am J Respir Cell Mol Biol 1996;15:645655.
  • 3
    Woolley MJ, Denburg JA, Ellis R, Dahlback M, O’Byrne PM. Allergen- induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol 1994;11:600606.
  • 4
    Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O’Byrne PM et al. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow- derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 1997;100:24662475.
  • 5
    Gaspar Elsas MI, Joseph D, Elsas PX, Vargaftig BB. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge. Am J Respir Cell Mol Biol 1997;17:404413.
  • 6
    Ohkawara Y, Lei XF, Stampfli MR, Marshall JS, Xing Z, Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 1997;16:510520.
  • 7
    Tomaki M, Zhao LL, Lundahl J, Sjostrand M, Jordana M, Linden A et al. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha. J Immunol 2000;165: 40404050.
  • 8
    Minshall EM, Schleimer R, Cameron L, Minnicozzi M, Egan RW, Gutierrez-Ramos JC et al. Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. Am J Respir Crit Care Med 1998;158:951957.
  • 9
    Inman MD, Denburg JA, Ellis R, Dahlback M, O’Byrne PM. Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: regulation by a serum hemopoietic factor. Am J Respir Cell Mol Biol 1996;15:305311.
  • 10
    Koury MJ. Programmed cell death (apoptosis) in hematopoiesis. Exp Hematol 1992;20:391394.
  • 11
    Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 1993;74:823832.
  • 12
    Johansson AK, Sjostrand M, Tomaki M, Samulesson AM, Lotvall J. Allergen stimulates bone marrow CD34(+) cells to release IL-5 in vitro; a mechanism involved in eosinophilic inflammation? Allergy 2004;59:10801086.
  • 13
    Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N et al. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:4356.
  • 14
    Wood LJ, Sehmi R, Dorman S, Hamid Q, Tulic MK, Watson RM et al. Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma. Am J Respir Crit Care Med 2002;166: 883889.
  • 15
    Radinger M, Sergejeva S, Johansson AK, Malmhall C, Bossios A, Sjostrand M et al. Regulatory role of CD8+ T lymphocytes in bone marrow eosinophilopoiesis. Respir Res 2006;7:83.
  • 16
    Hogan MB, Weissman DN, Hubbs AF, Gibson LF, Piktel D, Landreth KS. Regulation of eosinophilopoiesis in a murine model of asthma. J Immunol 2003;171:26442651.
  • 17
    Larson KA, Horton MA, Madden BJ, Gleich GJ, Lee NA, Lee JJ. The identification and cloning of a murine major basic protein gene expressed in eosinophils. J Immunol 1995;155:30023012.
  • 18
    Al-Rabia MW, Blaylock MG, Sexton DW, Thomson L, Walsh GM. Granule protein changes and membrane receptor phenotype in maturing human eosinophils cultured from CD34+ progenitors. Clin Exp Allergy 2003;33: 640648.
  • 19
    Hogan MB, Piktel D, Landreth KS. IL-5 production by bone marrow stromal cells: implications for eosinophilia associated with asthma. J Allergy Clin Immunol 2000;106:329336.
  • 20
    Wang J, Palmer K, Lotvall J, Milan S, Lei XF, Matthaei KI et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998;102:11321141.
  • 21
    Lamkhioued B, Abdelilah SG, Hamid Q, Mansour N, Delespesse G, Renzi PM. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells. J Immunol 2003;170:537547.
  • 22
    Sehmi R, Dorman S, Baatjes A, Watson R, Foley R, Ying S et al. Allergen- induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology 2003;109:536546.
  • 23
    Southam DS, Widmer N, Ellis R, Hirota JA, Inman MD, Sehmi R. Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice. J Allergy Clin Immunol 2005;115:95102.
  • 24
    Sitkauskiene B, Johansson AK, Sergejeva S, Lundin S, Sjostrand M, Lotvall J. Regulation of bone marrow and airway CD34+ eosinophils by interleukin-5. Am J Respir Cell Mol Biol 2004;30:367378.
  • 25
    Menzies-Gow A, Flood-Page P, Sehmi R, Burman J, Hamid Q, Robinson DS et al. Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 2003;111:714719.
  • 26
    Koo GC, Shah K, Ding GJ, Xiao J, Wnek R, Doherty G et al. A small molecule very late antigen-4 antagonist can inhibit ovalbumin-induced lung inflammation. Am J Respir Crit Care Med 2003;167:14001409.
  • 27
    Okigami H, Takeshita K, Tajimi M, Komura H, Albers M, Lehmann TE et al. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4. Eur J Pharmacol 2007;559:202209.
  • 28
    Ravensberg AJ, Luijk B, Westers P, Hiemstra PS, Sterk PJ, Lammers JW et al. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma. Allergy 2006;61:10971103.
  • 29
    Miyahara N, Takeda K, Miyahara S, Taube C, Joetham A, Koya T et al. Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8+ T cells and airway hyperresponsiveness. J Immunol 2005;174:49794984.
  • 30
    Miyahara N, Swanson BJ, Takeda K, Taube C, Miyahara S, Kodama T et al. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Nat Med 2004;10:865869.
  • 31
    Crosby JR, Shen HH, Borchers MT, Justice JP, Ansay T, Lee JJ et al. Ectopic expression of IL-5 identifies an additional CD4(+) T cell mechanism of airway eosinophil recruitment. Am J Physiol Lung Cell Mol Physiol 2002;282:L99L108.
  • 32
    Radinger M, Johansson AK, Sitkauskiene B, Sjostrand M, Lotvall J. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J Allergy Clin Immunol 2004;113:11091116.